nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—Biliary colic—Riluzole—amyotrophic lateral sclerosis	0.0206	0.0259	CcSEcCtD
Zaleplon—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0199	CcSEcCtD
Zaleplon—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0194	CcSEcCtD
Zaleplon—Trismus—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0189	CcSEcCtD
Zaleplon—TSPO—hindlimb—amyotrophic lateral sclerosis	0.0138	0.0979	CbGeAlD
Zaleplon—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0169	CcSEcCtD
Zaleplon—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0166	CcSEcCtD
Zaleplon—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0154	CcSEcCtD
Zaleplon—TSPO—appendage—amyotrophic lateral sclerosis	0.0119	0.084	CbGeAlD
Zaleplon—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0149	CcSEcCtD
Zaleplon—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0135	CcSEcCtD
Zaleplon—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0131	CcSEcCtD
Zaleplon—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0131	CcSEcCtD
Zaleplon—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0127	CcSEcCtD
Zaleplon—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00996	0.0125	CcSEcCtD
Zaleplon—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00956	0.012	CcSEcCtD
Zaleplon—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00956	0.012	CcSEcCtD
Zaleplon—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00908	0.0114	CcSEcCtD
Zaleplon—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00896	0.0113	CcSEcCtD
Zaleplon—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00886	0.0111	CcSEcCtD
Zaleplon—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00886	0.0111	CcSEcCtD
Zaleplon—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00845	0.0106	CcSEcCtD
Zaleplon—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00835	0.0105	CcSEcCtD
Zaleplon—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00817	0.0103	CcSEcCtD
Zaleplon—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.008	0.01	CcSEcCtD
Zaleplon—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.008	0.01	CcSEcCtD
Zaleplon—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00767	0.00964	CcSEcCtD
Zaleplon—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00745	0.0527	CbGeAlD
Zaleplon—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00744	0.00935	CcSEcCtD
Zaleplon—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00926	CcSEcCtD
Zaleplon—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0073	0.00917	CcSEcCtD
Zaleplon—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00717	0.009	CcSEcCtD
Zaleplon—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0071	0.00892	CcSEcCtD
Zaleplon—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0071	0.00892	CcSEcCtD
Zaleplon—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00704	0.00884	CcSEcCtD
Zaleplon—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00704	0.00884	CcSEcCtD
Zaleplon—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00697	0.00876	CcSEcCtD
Zaleplon—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00697	0.00876	CcSEcCtD
Zaleplon—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00681	0.0482	CbGeAlD
Zaleplon—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00846	CcSEcCtD
Zaleplon—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00667	0.00839	CcSEcCtD
Zaleplon—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00658	0.0466	CbGeAlD
Zaleplon—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00656	0.00825	CcSEcCtD
Zaleplon—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00625	0.00785	CcSEcCtD
Zaleplon—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00779	CcSEcCtD
Zaleplon—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00593	0.00745	CcSEcCtD
Zaleplon—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00724	CcSEcCtD
Zaleplon—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0056	0.00704	CcSEcCtD
Zaleplon—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00699	CcSEcCtD
Zaleplon—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00553	0.00694	CcSEcCtD
Zaleplon—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00549	0.0069	CcSEcCtD
Zaleplon—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00545	0.00685	CcSEcCtD
Zaleplon—Gout—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00676	CcSEcCtD
Zaleplon—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00535	0.00672	CcSEcCtD
Zaleplon—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00531	0.00668	CcSEcCtD
Zaleplon—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00531	0.00668	CcSEcCtD
Zaleplon—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00663	CcSEcCtD
Zaleplon—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00647	CcSEcCtD
Zaleplon—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00643	CcSEcCtD
Zaleplon—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00631	CcSEcCtD
Zaleplon—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00631	CcSEcCtD
Zaleplon—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00631	CcSEcCtD
Zaleplon—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00624	CcSEcCtD
Zaleplon—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00617	CcSEcCtD
Zaleplon—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0061	CcSEcCtD
Zaleplon—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0061	CcSEcCtD
Zaleplon—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00477	0.00599	CcSEcCtD
Zaleplon—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00593	CcSEcCtD
Zaleplon—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00571	CcSEcCtD
Zaleplon—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00553	CcSEcCtD
Zaleplon—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00548	CcSEcCtD
Zaleplon—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00542	CcSEcCtD
Zaleplon—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00537	CcSEcCtD
Zaleplon—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00537	CcSEcCtD
Zaleplon—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00427	0.0302	CbGeAlD
Zaleplon—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00527	CcSEcCtD
Zaleplon—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00415	0.00522	CcSEcCtD
Zaleplon—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00512	CcSEcCtD
Zaleplon—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00512	CcSEcCtD
Zaleplon—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0051	CcSEcCtD
Zaleplon—TSPO—embryo—amyotrophic lateral sclerosis	0.00394	0.0279	CbGeAlD
Zaleplon—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00494	CcSEcCtD
Zaleplon—GABRA2—brainstem—amyotrophic lateral sclerosis	0.0039	0.0276	CbGeAlD
Zaleplon—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00488	CcSEcCtD
Zaleplon—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00488	CcSEcCtD
Zaleplon—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00482	CcSEcCtD
Zaleplon—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00476	CcSEcCtD
Zaleplon—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00377	0.0267	CbGeAlD
Zaleplon—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00474	CcSEcCtD
Zaleplon—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00472	CcSEcCtD
Zaleplon—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00458	CcSEcCtD
Zaleplon—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00458	CcSEcCtD
Zaleplon—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00455	CcSEcCtD
Zaleplon—TSPO—brainstem—amyotrophic lateral sclerosis	0.00361	0.0256	CbGeAlD
Zaleplon—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00451	CcSEcCtD
Zaleplon—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00451	CcSEcCtD
Zaleplon—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00448	CcSEcCtD
Zaleplon—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00442	CcSEcCtD
Zaleplon—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00436	CcSEcCtD
Zaleplon—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00434	CcSEcCtD
Zaleplon—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00431	CcSEcCtD
Zaleplon—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00423	CcSEcCtD
Zaleplon—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00419	CcSEcCtD
Zaleplon—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00414	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00413	CcSEcCtD
Zaleplon—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00406	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00404	CcSEcCtD
Zaleplon—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00404	CcSEcCtD
Zaleplon—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00396	CcSEcCtD
Zaleplon—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00396	CcSEcCtD
Zaleplon—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00386	CcSEcCtD
Zaleplon—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00381	CcSEcCtD
Zaleplon—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00298	0.0211	CbGeAlD
Zaleplon—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00298	0.0211	CbGeAlD
Zaleplon—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0037	CcSEcCtD
Zaleplon—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.00294	0.0469	CbGpPWpGaD
Zaleplon—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00366	CcSEcCtD
Zaleplon—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00365	CcSEcCtD
Zaleplon—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00362	CcSEcCtD
Zaleplon—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00361	CcSEcCtD
Zaleplon—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00358	CcSEcCtD
Zaleplon—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00355	CcSEcCtD
Zaleplon—Depression—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00352	CcSEcCtD
Zaleplon—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00346	CcSEcCtD
Zaleplon—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00344	CcSEcCtD
Zaleplon—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00339	CcSEcCtD
Zaleplon—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00337	CcSEcCtD
Zaleplon—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00334	CcSEcCtD
Zaleplon—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00266	0.0188	CbGeAlD
Zaleplon—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00266	0.0188	CbGeAlD
Zaleplon—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00333	CcSEcCtD
Zaleplon—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00263	0.0186	CbGeAlD
Zaleplon—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.00252	0.0178	CbGeAlD
Zaleplon—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00315	CcSEcCtD
Zaleplon—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00315	CcSEcCtD
Zaleplon—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00312	CcSEcCtD
Zaleplon—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00296	CcSEcCtD
Zaleplon—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00235	0.0166	CbGeAlD
Zaleplon—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00229	0.0162	CbGeAlD
Zaleplon—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00286	CcSEcCtD
Zaleplon—Chills—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00285	CcSEcCtD
Zaleplon—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00225	0.0159	CbGeAlD
Zaleplon—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00224	0.0158	CbGeAlD
Zaleplon—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00224	0.0158	CbGeAlD
Zaleplon—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0028	CcSEcCtD
Zaleplon—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00278	CcSEcCtD
Zaleplon—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00276	CcSEcCtD
Zaleplon—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00272	CcSEcCtD
Zaleplon—Tension—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00271	CcSEcCtD
Zaleplon—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00216	0.0152	CbGeAlD
Zaleplon—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00216	0.0152	CbGeAlD
Zaleplon—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0027	CcSEcCtD
Zaleplon—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00268	CcSEcCtD
Zaleplon—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00267	CcSEcCtD
Zaleplon—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00211	0.0149	CbGeAlD
Zaleplon—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00211	0.0149	CbGeAlD
Zaleplon—AOX1—cerebellum—amyotrophic lateral sclerosis	0.00209	0.0148	CbGeAlD
Zaleplon—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00259	CcSEcCtD
Zaleplon—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00205	0.0145	CbGeAlD
Zaleplon—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00204	0.0144	CbGeAlD
Zaleplon—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00256	CcSEcCtD
Zaleplon—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00255	CcSEcCtD
Zaleplon—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00254	CcSEcCtD
Zaleplon—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00252	CcSEcCtD
Zaleplon—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00249	CcSEcCtD
Zaleplon—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00198	0.014	CbGeAlD
Zaleplon—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00248	CcSEcCtD
Zaleplon—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00248	CcSEcCtD
Zaleplon—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00197	0.0139	CbGeAlD
Zaleplon—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00244	CcSEcCtD
Zaleplon—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00243	CcSEcCtD
Zaleplon—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00192	0.0136	CbGeAlD
Zaleplon—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.0019	0.0135	CbGeAlD
Zaleplon—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00238	CcSEcCtD
Zaleplon—TSPO—nervous system—amyotrophic lateral sclerosis	0.00189	0.0134	CbGeAlD
Zaleplon—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00235	CcSEcCtD
Zaleplon—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00235	CcSEcCtD
Zaleplon—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00235	CcSEcCtD
Zaleplon—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00234	CcSEcCtD
Zaleplon—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00186	0.0132	CbGeAlD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00233	CcSEcCtD
Zaleplon—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00232	CcSEcCtD
Zaleplon—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0023	CcSEcCtD
Zaleplon—TSPO—central nervous system—amyotrophic lateral sclerosis	0.00182	0.0129	CbGeAlD
Zaleplon—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00227	CcSEcCtD
Zaleplon—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00225	CcSEcCtD
Zaleplon—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00225	CcSEcCtD
Zaleplon—TSPO—cerebellum—amyotrophic lateral sclerosis	0.00178	0.0126	CbGeAlD
Zaleplon—Shock—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00222	CcSEcCtD
Zaleplon—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00221	CcSEcCtD
Zaleplon—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0022	CcSEcCtD
Zaleplon—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00219	CcSEcCtD
Zaleplon—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00218	CcSEcCtD
Zaleplon—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00172	0.0122	CbGeAlD
Zaleplon—GABRB2—brain—amyotrophic lateral sclerosis	0.00171	0.0121	CbGeAlD
Zaleplon—GABRG2—brain—amyotrophic lateral sclerosis	0.00171	0.0121	CbGeAlD
Zaleplon—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00215	CcSEcCtD
Zaleplon—AOX1—brain—amyotrophic lateral sclerosis	0.00169	0.012	CbGeAlD
Zaleplon—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0021	CcSEcCtD
Zaleplon—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00165	0.0117	CbGeAlD
Zaleplon—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00205	CcSEcCtD
Zaleplon—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00204	CcSEcCtD
Zaleplon—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00162	0.0114	CbGeAlD
Zaleplon—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00202	CcSEcCtD
Zaleplon—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00201	CcSEcCtD
Zaleplon—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00159	0.002	CcSEcCtD
Zaleplon—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00198	CcSEcCtD
Zaleplon—GABRA2—brain—amyotrophic lateral sclerosis	0.00156	0.0111	CbGeAlD
Zaleplon—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00196	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00194	CcSEcCtD
Zaleplon—Pain—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00193	CcSEcCtD
Zaleplon—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00193	CcSEcCtD
Zaleplon—GABRA1—brain—amyotrophic lateral sclerosis	0.00151	0.0107	CbGeAlD
Zaleplon—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00186	CcSEcCtD
Zaleplon—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00184	CcSEcCtD
Zaleplon—GABRB2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00146	0.0233	CbGpPWpGaD
Zaleplon—TSPO—brain—amyotrophic lateral sclerosis	0.00145	0.0102	CbGeAlD
Zaleplon—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00179	CcSEcCtD
Zaleplon—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00178	CcSEcCtD
Zaleplon—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00178	CcSEcCtD
Zaleplon—GABRA2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00137	0.0219	CbGpPWpGaD
Zaleplon—GABRB3—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00136	0.0217	CbGpPWpGaD
Zaleplon—GABRG2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00134	0.0213	CbGpPWpGaD
Zaleplon—GABRB3—brain—amyotrophic lateral sclerosis	0.00131	0.0093	CbGeAlD
Zaleplon—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00162	CcSEcCtD
Zaleplon—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00159	CcSEcCtD
Zaleplon—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00149	CcSEcCtD
Zaleplon—GABRA1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00117	0.0186	CbGpPWpGaD
Zaleplon—Rash—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00142	CcSEcCtD
Zaleplon—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00142	CcSEcCtD
Zaleplon—Headache—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00141	CcSEcCtD
Zaleplon—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00134	CcSEcCtD
Zaleplon—GABRB3—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.000951	0.0152	CbGpPWpGaD
Zaleplon—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00088	0.00623	CbGeAlD
Zaleplon—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000847	0.00599	CbGeAlD
Zaleplon—GABRB2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000828	0.0132	CbGpPWpGaD
Zaleplon—GABRA2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000776	0.0124	CbGpPWpGaD
Zaleplon—GABRB3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000771	0.0123	CbGpPWpGaD
Zaleplon—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000757	0.0121	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000673	0.0107	CbGpPWpGaD
Zaleplon—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000662	0.0106	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000631	0.0101	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000627	0.00999	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000621	0.0099	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000615	0.00981	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000582	0.00928	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00058	0.00925	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000578	0.00922	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000568	0.00905	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.000566	0.00901	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000549	0.00874	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000538	0.00857	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000514	0.0082	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000511	0.00814	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000506	0.00806	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000502	0.00799	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000496	0.00791	CbGpPWpGaD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000494	0.00788	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000474	0.00756	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000471	0.00751	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000467	0.00744	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000463	0.00737	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000451	0.00718	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000439	0.00699	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000438	0.00697	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000435	0.00693	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000427	0.0068	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000423	0.00674	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00042	0.00669	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000412	0.00657	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000412	0.00657	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000404	0.00644	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000404	0.00644	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000388	0.00618	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000387	0.00616	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000384	0.00612	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000383	0.00611	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000383	0.00611	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000382	0.00609	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000377	0.00601	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000374	0.00596	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000374	0.00596	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000374	0.00596	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000373	0.00595	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000363	0.00579	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000361	0.00575	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00036	0.00574	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000359	0.00573	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000359	0.00573	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000358	0.0057	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000357	0.00569	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000357	0.00569	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000355	0.00565	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000351	0.00559	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000351	0.00559	CbGpPWpGaD
Zaleplon—AOX1—Disease—TPK1—amyotrophic lateral sclerosis	0.000348	0.00555	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000345	0.00551	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000342	0.00545	CbGpPWpGaD
Zaleplon—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.00034	0.00542	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000335	0.00534	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000333	0.00531	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00033	0.00525	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000327	0.00521	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000324	0.00516	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000322	0.00513	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00032	0.0051	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000319	0.00508	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000318	0.00507	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000316	0.00503	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000316	0.00503	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000313	0.00498	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00031	0.00494	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000306	0.00488	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000306	0.00488	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000296	0.00472	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000294	0.00469	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000294	0.00468	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000294	0.00468	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000292	0.00465	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000292	0.00465	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000289	0.00461	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000288	0.00459	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000286	0.00456	CbGpPWpGaD
Zaleplon—AOX1—Disease—VTA1—amyotrophic lateral sclerosis	0.000278	0.00444	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000276	0.0044	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000276	0.0044	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000275	0.00439	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000275	0.00439	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000274	0.00436	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000274	0.00436	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000273	0.00435	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00027	0.00431	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000269	0.00428	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000269	0.00428	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000268	0.00428	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000267	0.00425	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000264	0.0042	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000262	0.00417	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000253	0.00403	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000248	0.00395	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000245	0.00391	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000244	0.00389	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.00024	0.00383	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000239	0.00382	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000235	0.00374	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000235	0.00374	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000233	0.00371	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00023	0.00367	CbGpPWpGaD
Zaleplon—AOX1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000211	0.00336	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000211	0.00336	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000209	0.00334	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000193	0.00308	CbGpPWpGaD
Zaleplon—AOX1—Disease—PLB1—amyotrophic lateral sclerosis	0.000191	0.00304	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000186	0.00296	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000174	0.00277	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000173	0.00276	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000171	0.00272	CbGpPWpGaD
Zaleplon—AOX1—Disease—VCP—amyotrophic lateral sclerosis	0.00017	0.00271	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00017	0.00271	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000169	0.00269	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00016	0.00255	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000158	0.00252	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000158	0.00252	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000148	0.00237	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000148	0.00236	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000148	0.00236	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000147	0.00235	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000147	0.00234	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000147	0.00234	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000144	0.0023	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000144	0.0023	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000141	0.00224	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000132	0.0021	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000131	0.00209	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000131	0.00209	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000131	0.00209	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000129	0.00205	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000128	0.00205	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000126	0.00201	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000126	0.00201	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000124	0.00197	CbGpPWpGaD
Zaleplon—AOX1—Disease—CST3—amyotrophic lateral sclerosis	0.000122	0.00194	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000122	0.00194	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000121	0.00193	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.00012	0.00191	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00012	0.00191	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000113	0.00179	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000111	0.00177	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000105	0.00167	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	9.66e-05	0.00154	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	9.47e-05	0.00151	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	9.47e-05	0.00151	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	9.47e-05	0.00151	CbGpPWpGaD
Zaleplon—AOX1—Disease—CASP9—amyotrophic lateral sclerosis	8.87e-05	0.00141	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	8.66e-05	0.00138	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	8.2e-05	0.00131	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.05e-05	0.00128	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB4—amyotrophic lateral sclerosis	7.6e-05	0.00121	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	7.57e-05	0.00121	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	7.18e-05	0.00114	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	6.84e-05	0.00109	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	6.62e-05	0.00106	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.51e-05	0.00104	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.98e-05	0.000953	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOE—amyotrophic lateral sclerosis	5.88e-05	0.000936	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.74e-05	0.000915	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.66e-05	0.000903	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	5.44e-05	0.000867	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	5.19e-05	0.000826	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOE—amyotrophic lateral sclerosis	4.92e-05	0.000784	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	4.79e-05	0.000763	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.4e-05	0.000701	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.4e-05	0.000701	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—amyotrophic lateral sclerosis	4.03e-05	0.000642	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.03e-05	0.000641	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	3.93e-05	0.000626	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.74e-05	0.000596	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.52e-05	0.000561	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.37e-05	0.000537	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.18e-05	0.000507	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.92e-05	0.000466	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.69e-05	0.000428	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.41e-05	0.000384	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.23e-05	0.000355	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	2.21e-05	0.000352	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.11e-05	0.000337	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	0.000309	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.83e-05	0.000291	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.6e-05	0.000255	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.51e-05	0.000241	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.000174	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.82e-06	0.000157	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.03e-06	0.000144	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	7.43e-06	0.000118	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.09e-06	8.11e-05	CbGpPWpGaD
